GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AddLife AB (OSTO:ALIF B) » Definitions » Cyclically Adjusted Revenue per Share

AddLife AB (OSTO:ALIF B) Cyclically Adjusted Revenue per Share : kr55.19 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is AddLife AB Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

AddLife AB's adjusted revenue per share for the three months ended in Mar. 2025 was kr22.172. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is kr55.19 for the trailing ten years ended in Mar. 2025.

During the past 12 months, AddLife AB's average Cyclically Adjusted Revenue Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-07-01), AddLife AB's current stock price is kr188.70. AddLife AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr55.19. AddLife AB's Cyclically Adjusted PS Ratio of today is 3.42.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of AddLife AB was 3.60. The lowest was 1.97. And the median was 2.79.


AddLife AB Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for AddLife AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AddLife AB Cyclically Adjusted Revenue per Share Chart

AddLife AB Annual Data
Trend Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 53.46

AddLife AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.76 50.82 51.32 53.46 55.19

Competitive Comparison of AddLife AB's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, AddLife AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AddLife AB's Cyclically Adjusted PS Ratio falls into.


;
;

AddLife AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AddLife AB's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=22.172/132.8245*132.8245
=22.172

Current CPI (Mar. 2025) = 132.8245.

AddLife AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 3.999 99.995 5.312
201509 4.477 100.228 5.933
201512 5.704 100.276 7.555
201603 4.991 100.751 6.580
201606 4.791 101.019 6.299
201609 3.958 101.138 5.198
201612 5.967 102.022 7.769
201703 5.620 102.022 7.317
201706 5.581 102.752 7.214
201709 5.054 103.279 6.500
201712 6.545 103.793 8.376
201803 5.880 103.962 7.512
201806 6.127 104.875 7.760
201809 5.725 105.679 7.196
201812 6.951 105.912 8.717
201903 7.920 105.886 9.935
201906 7.477 106.742 9.304
201909 7.132 107.214 8.836
201912 8.805 107.766 10.852
202003 9.351 106.563 11.655
202006 11.117 107.498 13.736
202009 11.058 107.635 13.646
202012 15.083 108.296 18.499
202103 15.363 108.360 18.832
202106 18.774 108.928 22.893
202109 15.171 110.338 18.263
202112 17.193 112.486 20.302
202203 21.174 114.825 24.493
202206 17.082 118.384 19.166
202209 17.150 122.296 18.626
202212 18.658 126.365 19.612
202303 20.051 127.042 20.964
202306 19.408 129.407 19.921
202309 19.031 130.224 19.411
202312 20.877 131.912 21.021
202403 21.090 132.205 21.189
202406 20.958 132.716 20.975
202409 19.235 132.304 19.311
202412 23.124 132.987 23.096
202503 22.172 132.825 22.172

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


AddLife AB  (OSTO:ALIF B) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

AddLife AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=188.70/55.19
=3.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of AddLife AB was 3.60. The lowest was 1.97. And the median was 2.79.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


AddLife AB Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of AddLife AB's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


AddLife AB Business Description

Industry
Traded in Other Exchanges
Address
Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals and laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

AddLife AB Headlines

No Headlines